Amniotic membrane transplantation-a new approach to crossing the HLA barriers in the treatment of refractory ocular graft-versus-host disease

被引：15
|
作者：
Peric, Zinaida [1 ,2 ]
Skegro, Ivan [3 ]
Durakovic, Nadira [1 ,2 ]
Desnica, Lana [1 ]
Pulanic, Drazen [1 ,2 ]
Serventi-Seiwerth, Ranka [1 ]
Petricek, Igor [2 ,3 ]
Pavletic, Steven Z. [4 ]
Vrhovac, Radovan [1 ,2 ]
机构：
[1] Univ Hosp Ctr, Dept Hematol, Zagreb, Croatia
[2] Univ Zagreb, Sch Med, Zagreb, Croatia
[3] Univ Hosp Ctr, Dept Ophtalmol, Zagreb, Croatia
[4] NCI, NIH, Bethesda, MD 20892 USA
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷 / 11期
关键词：
SUPPRESSION; DIAGNOSIS;
D O I：
10.1038/s41409-018-0140-6
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1466 / 1469
页数：4
相关论文
共 50 条
  • [31] Ocular manifestations and treatment outcomes of patients with graft-versus-host disease
    Mahesh, Sankaranarayana
    Rapuano, Christopher
    Nagra, Parveen
    Hammersmith, Kristin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [32] 'Window of Opportunity'in Ocular Graft-versus-Host Disease (oGVHD) Treatment
    Mun, Christine
    Sheth, Tanya
    Surenkhuu, Bayasgalan
    Kim, Christian
    Jain, Sandeep
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [33] The use of Topical Spironolactone in Treatment of Ocular Graft-Versus-Host Disease
    Wong, Calvin
    Lu, Xiaowen
    Watsky, Mitchell
    Yee, Richard
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [34] Ocular Graft-Versus-Host Disease After Allogeneic Stem Cell Transplantation
    Westeneng, Arnaud C.
    Hettinga, Ymkje
    Lokhorst, Henk
    Verdonck, Leo
    van Dorp, Suzanne
    Rothova, Aniki
    CORNEA, 2010, 29 (07) : 758 - 763
  • [35] Ocular involvement in graft-versus-host disease after bone marrow transplantation
    Mittelviefhaus, H
    OPHTHALMOLOGE, 2000, 97 (03): : 228 - 242
  • [36] Confirmation of graft-versus-host disease by HLA typing after liver transplantation
    Arrieta, A
    Maruri, N
    Riñón, M
    Fernández, JR
    de Urbina, JO
    Masdevall, MDG
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (01) : 278 - 279
  • [37] Use of HLA typing in the diagnostics of graft-versus-host disease of organ transplantation
    Salmela, K
    Turakainen, H
    Lautenschlager, I
    Koskimies, S
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : P739 - P739
  • [38] Ruxolitinib treatment for steroid-refractory graft-versus-host disease
    Park, Han-Seung
    Lee, Je-Hwan
    Lee, Jung-Hee
    Choi, Eun-Ji
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Lee, Kyoo-Hyung
    BONE MARROW TRANSPLANTATION, 2019, 54 : 323 - 324
  • [39] Improving treatment of refractory chronic extensive graft-versus-host disease
    Elez, M.
    Stamatovic, D.
    Tukic, L.
    Tarabar, O.
    Balint, B.
    Skuletic, V.
    Tasic, O.
    Simic, L.
    Malesevic, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S413 - S414
  • [40] Insulin eye drops for severe refractory chronic ocular graft-versus-host disease
    Tahmaz, V.
    Menghesha, L.
    Stern, M. E.
    Holtick, U.
    Scheid, C.
    Steven, P.
    BONE MARROW TRANSPLANTATION, 2024, 59 (07) : 1031 - 1033
12345